Les urgences ophtalmologiques chez le chien et le chat

Les urgences ophtalmologiques sont constituées par toutes les affections oculaires qui s'accomptagnent d'une douleur importante, de la diminution ou de la perte de la vision, et qui risquent de se traduire si elles ne sont pas traitées rapidement par un préjudice fonctionnel ou esthétique grave et irréversible. Dans cette étude, l'auteur aborde les urgences oculaires en fonction de la région anatomique de l'oeil qui est atteinte. L'étiologie, les éléments diagnostiques, le traitement d'urgence et le pronostic seront abordés pour chaque affection

Évaluation des risques écologiques causés par des matériaux de dragage: roposition d'une approche adaptée aux dépôts en gravière en eau

Une procédure d'évaluation des risques pour l'écosystème aquatique engendrés par un dépôt de matériaux de dragage dans une gravière type a été élaborée, et testée avec des échantillons de sédiments d'un canal du Nord-Est de la France. La procédure comporte une étape d'évaluation sommaire des risques, à partir de quotients des concentrations mesurées par les critères de danger correspondants, et une étape d'évaluation détaillée où des essais de toxicité et de lixiviation en colonnes sont mis en œuvre. Le scénario testé retient trois hypothèses, qui concernent (a) les effets sur les peuplements d'invertébrés benthiques, représentés notamment par Hyalella azteca et Chironomus riparius, (b) les effets sur les peuplements d'organismes pélagiques, représentés par Chlorella vulgaris, Ceriodaphnia dubia, et Brachionus calyciflorus, et (c) la pollution de la nappe alluviale associée. Différentes modalités d'exposition (essais normalisés, microcosmes) ont été testées. Dans le contexte particulier des trois sédiments étudiés, ces hypothèses se sont avérées plus ou moins discriminantes, la pollution de la nappe étant la plus sensible. Des améliorations de la procédure doivent être envisagées qui concernent à la fois la formulation des hypothèses (risques à court et long terme sur les organismes pélagiques), et les protocoles d'essai, tant pour les organismes du sédiment (rôle de la nourriture notamment) que pour les essais de lixiviation en colonnes.When contaminated by metals or synthetic organic compounds, dredged sediments may have negative impacts on receiving ecosystems. Therefore, there is a need for an operational risk assessment approach. Such a framework is proposed for dredged material deposits in open gravel quarries, which is a rather common means of disposal in France. The first step of the assessment relies upon chemical characterisation of the sediments; the resulting concentrations are divided by "probable effect concentrations" and pooled together, in order to calculate a global hazard quotient. According to the value of this quotient, several decisions can be taken: (a) undertake a detailed risk assessment, (b) dispose of the materials without further constraints, or (c) in case of uncertainty, do some biological testing (with Hyalella azteca and Chironomus riparius) in order to allow decisions. The second step is a detailed ecological risk assessment. Three different assessment endpoints have been proposed, which are (1) the deposit should have no effect on the structure and abundance of benthic invertebrates in the quarry, (2) it should have no long term effect on pelagic species, and (3) it should not cause groundwater pollution, as such quarries are in fact cross sections of shallow alluvial groundwater aquifers. A fourth assessment endpoint should be introduced, regarding health risks for recreational uses, including fishing, but this endpoint was not implemented in the current version of the approach. The analysis phase includes aquatic bioassays (bacteria - Metplate TM-, algae, microcrustaceans Ceriodaphnia dubia, rotifers Brachionus calyciflorus), and leaching assays in columns under ascendant flow.The proposed approach was tested with 3 sediments from a canal located in the north-eastern region of France. Microcosm assays were introduced in parallel to the proposed tests, in order to explore alternatives to standardised bioassays. According to their hazard quotient, the 3 sediments showed a contamination gradient; one of them should not have entered the detailed risk assessment phase, while another would have been further tested with H. azteca and C. riparius. In that case, this latter sediment would not have entered the detailed phase either, as it was not toxic to these species. However, the detailed risk assessment approach was applied to the three sediments, so as to test completely the relevance of the framework.The three sediments were not significantly toxic to either C. riparius or H. azteca. However, some effects were observed in microcosms, including genotoxicity to molluscs. In this case, no risk characterisation could be made. Pore waters extracted from the three sediments were not toxic or slightly toxic to bacteria, algae, and C. dubia; an EC10 value could be determined only for B. calyciflorus. Therefore, due to exposure calculations, it seems there is a risk to pelagic species. However, as 3 bioassays out of 4 were negative or inconclusive, a refinement step would seem to be necessary. The highest concentrations of cadmium, copper, chromium, nickel and zinc were measured in the first lixiviates of the most contaminated sediment. Yet, even in that case, the total extracted fraction remained less than 10% of the total load. This fraction was below 1% for the other sediments, whatever the metal. Maximum concentrations and predicted concentrations at 1 year were compared to drinking water standards. This comparison showed a real risk of degrading groundwater quality for that most contaminated sediment, and a transient risk due to cadmium and nickel for the following one on the contamination gradient.Considering these results, the design of the first step of the proposed assessment approach may be discussed, as one sediment which would not have been assessed in depth according to its hazard quotient did show a risk to pelagic species. This discrepancy underlines the fact that some sediment toxicity may exist below the lowest threshold. As it would be unrealistic to enter systematically into detailed risk assessments, the proposed thresholds in the decision diagram must be pragmatic compromises rather than absolutely safe boundaries. Moreover, protocol improvements are needed for sediment toxicity bioassays. Chronic endpoints are preferable, as they are more sensitive and more relevant. Another issue is related to the role of additional food: not adding food may increase the apparent toxicity, but the sediment organic content, which is an alternative food source, may also be a contaminant carrier. Furthermore, the second assessment endpoint (risk to pelagic species) should be reformulated, as it includes in fact two different questions. Short-term risks related to the deposition phase could be assessed with standardised bioassays like C. dubia survival and reproduction and algal growth, while longer term risks related to contaminant diffusion could be assessed with microcosms. Genotoxic effects were observed at rather high levels, as compared to published results. This result stresses the interest of introducing sensitive and early markers in the risk assessment process, although their real meaning for ecosystems is not yet fully elucidated. Finally, the leaching tests in columns are not completely satisfactory, as the column filling implies that one must first dry the sediments, which will alter their structure. Other application trials along with field validation studies should be carried out prior to the introduction of this scenario in operational or regulatory frameworks

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis

Mouse breast regression protein 39 (BRP-39; Chi3l1) and its human homologue YKL-40 are chitinase-like proteins that lack chitinase activity. Although YKL-40 is expressed in exaggerated quantities and correlates with disease activity in asthma and many other disorders, the biological properties of BRP-39/YKL-40 have only been rudimentarily defined. We describe the generation and characterization of BRP-39−/− mice, YKL-40 transgenic mice, and mice that lack BRP-39 and produce YKL-40 only in their pulmonary epithelium. Studies of these mice demonstrated that BRP-39−/− animals have markedly diminished antigen-induced Th2 responses and that epithelial YKL-40 rescues the Th2 responses in these animals. The ability of interleukin13 to induce tissue inflammation and fibrosis was also markedly diminished in the absence of BRP-39. Mechanistic investigations demonstrated that BRP-39 and YKL-40 play an essential role in antigen sensitization and immunoglobulin E induction, stimulate dendritic cell accumulation and activation, and induce alternative macrophage activation. These proteins also inhibit inflammatory cell apoptosis/cell death while inhibiting Fas expression, activating protein kinase B/AKT, and inducing Faim 3. These studies establish novel regulatory roles for BRP-39/YKL-40 in the initiation and effector phases of Th2 inflammation and remodeling and suggest that these proteins are therapeutic targets in Th2- and macrophage-mediated disorders

The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid

<p>Abstract</p> <p>Background</p> <p>Cerebrospinal fluid (CSF) contacts many brain regions and may mediate humoral signaling distinct from synaptic neurotransmission. However, synthesis and transport mechanisms for such signaling are not defined. The purpose of this study was to investigate whether human CSF contains discrete structures that may enable the regulation of humoral transmission.</p> <p>Methods</p> <p>Lumbar CSF was collected prospectively from 17 participants: with no neurological or psychiatric disease, with Alzheimer's disease, multiple sclerosis, or migraine; and ventricular CSF from two cognitively healthy participants with long-standing shunts for congenital hydrocephalus. Cell-free CSF was subjected to ultracentrifugation to yield supernatants and pellets that were examined by transmission electron microscopy, shotgun protein sequencing, electrophoresis, western blotting, lipid analysis, enzymatic activity assay, and immuno-electron microscopy.</p> <p>Results</p> <p>Over 3,600 CSF proteins were identified from repeated shotgun sequencing of cell-free CSF from two individuals with Alzheimer's disease: 25% of these proteins are normally present in membranes. Abundant nanometer-scaled structures were observed in ultracentrifuged pellets of CSF from all 16 participants examined. The most common structures included synaptic vesicle and exosome components in 30-200 nm spheres and irregular blobs. Much less abundant nanostructures were present that derived from cellular debris. Nanostructure fractions had a unique composition compared to CSF supernatant, richer in omega-3 and phosphoinositide lipids, active prostanoid enzymes, and fibronectin.</p> <p>Conclusion</p> <p>Unique morphology and biochemistry features of abundant and discrete membrane-bound CSF nanostructures are described. Prostaglandin H synthase activity, essential for prostanoid production and previously unknown in CSF, is localized to nanospheres. Considering CSF bulk flow and its circulatory dynamics, we propose that these nanostructures provide signaling mechanisms <it>via </it>volume transmission within the nervous system that are for slower, more diffuse, and of longer duration than synaptic transmission.</p

Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis

Immune responses need to be controlled tightly to prevent autoimmune diseases, yet underlying molecular mechanisms remain partially understood. Here, we identify biallelic mutations in three patients from two unrelated families in differentially expressed in FDCP6 homolog (DEF6) as the molecular cause of an inborn error of immunity with systemic autoimmunity. Patient T cells exhibit impaired regulation of CTLA-4 surface trafficking associated with reduced functional CTLA-4 availability, which is replicated in DEF6-knockout Jurkat cells. Mechanistically, we identify the small GTPase RAB11 as an interactor of the guanine nucleotide exchange factor DEF6, and find disrupted binding of mutant DEF6 to RAB11 as well as reduced RAB11+CTLA-4+ vesicles in DEF6-mutated cells. One of the patients has been treated with CTLA-4-Ig and achieved sustained remission. Collectively, we uncover DEF6 as player in immune homeostasis ensuring availability of the checkpoint protein CTLA-4 at T-cell surface, identifying a potential target for autoimmune and/or cancer therapy.Mechanistically, we identify the small GTPase RAB11 as an interactor of the guanine nucleotide exchange factor DEF6, and find disrupted binding of mutant DEF6 to RAB11 as well as reduced RAB11+CTLA-4+ vesicles in DEF6-mutated cells. One of the patients has been treated with CTLA-4-Ig and achieved sustained remission. Collectively, we uncover DEF6 as player in immune homeostasis ensuring availability of the checkpoint protein CTLA-4 at T-cell surface, identifying a potential target for autoimmune and/or cancer therapy

Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis

BACKGROUND. Antigen-specific regulation of autoimmune disease is a major goal. In seropositive rheumatoid arthritis (RA), T cell help to autoreactive B cells matures the citrullinated (Cit) antigen-specific immune response, generating RA-specific V domain glycosylated anti-Cit protein antibodies (ACPA VDG) before arthritis onset. Low or escalating antigen administration under “sub-immunogenic” conditions favors tolerance. We explored safety, pharmacokinetics, and immunological and clinical effects of s.c. DEN-181, comprising liposomes encapsulating self-peptide collagen II259-273 (CII) and NF-κB inhibitor 1,25-dihydroxycholecalciferol. METHODS. A double-blind, placebo-controlled, exploratory, single-ascending-dose, phase I trial assessed the impact of low, medium, and high DEN-181 doses on peripheral blood CII-specific and bystander Cit64vimentin59-71–specific (Cit-Vim–specific) autoreactive T cell responses, cytokines, and ACPA in 17 HLA-DRB1*04:01+ or *01:01+ ACPA+ RA patients on methotrexate. RESULTS. DEN-181 was well tolerated. Relative to placebo and normalized to baseline values, Cit-Vim–specific T cells decreased in patients administered medium and high doses of DEN-181. Relative to placebo, percentage of CII-specific programmed cell death 1+ T cells increased within 28 days of DEN-181. Exploratory analysis in DEN-181–treated patients suggested improved RA disease activity was associated with expansion of CII-specific and Cit-Vim–specific T cells; reduction in ACPA VDG, memory B cells, and inflammatory myeloid populations; and enrichment in CCR7+ and naive T cells. Single-cell sequencing identified T cell transcripts associated with tolerogenic TCR signaling and exhaustion after low or medium doses of DEN-181. CONCLUSION. The safety and immunomodulatory activity of low/medium DEN-181 doses provide rationale to further assess antigen-specific immunomodulatory therapy in ACPA+ RA

Spectre de CO obtenu à l'aide d'une lampe de Schüler. détermination des constantes moléculaires. répartition de l'intensité dans les bandes

Using a hollow cathode lamp (Schüler lamp) we have obtained the spectrum of CO in the ultraviolet region. We determine the B' value and we compare the theoretical intensity distribution with the record given by a microdensitometer.En prenant comme source une lampe à cathode creuse (lampe de Schuler) nous avons obtenu le spectre ultraviolet de CO et avons pu déterminer une nouvelle valeur de B' et de là une répartition de l'intensité dans le spectre que nous comparons aux enregistrements

Saint-André d'Hébertot au XVIIe et au XVIIIe siècles. Etude démographique

Becart Françoise. Saint-André d'Hébertot au XVIIe et au XVIIIe siècles. Etude démographique. In: Annales de Normandie, 27ᵉ année, n°3, 1977. pp. 281-294